Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania

Emerging Infectious Diseases

Volumn 19, Issue 9, 2013, Pages 1446-1454

  Minja, Daniel T R ^a,b   Schmiegelow, Christentze ^b   Mmbando, Bruno ^a   Boström, Stéphanie ^c   Oesterholt, Mayke ^d   Magistrado, Pamela ^a,b   Pehrson, Caroline ^b   John, Davis ^e   Salanti, Ali ^b   Luty, Adrian J F ^d,f   Lemnge, Martha ^a   Theander, Thor ^b   Lusingu, John ^a,b   Alifrangis, Michael ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^f UMR 216 Mère et Enfant Face Aux Infections Tropicales   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; QUININE SULFATE;

ADOLESCENT; ADULT; ARTICLE; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENOTYPING TECHNIQUE; GESTATIONAL AGE; HAPLOTYPE; HUMAN; LOW BIRTH WEIGHT; MALARIA FALCIPARUM; NEWBORN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; TANZANIA; ALLELE; DRUG RESISTANCE; GENETICS; INTERMITTENT PREVENTIVE TREATMENT; MALARIA; MUTATION; MUTATIONS; PARASITE; POLYMORPHISMS; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROSPECTIVE STUDY; SEXTUPLE; YOUNG ADULT; COMPLICATION; MALARIA, FALCIPARUM; PREGNANCY COMPLICATIONS, PARASITIC;

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHETASE; DRUG RESISTANCE; HAPLOTYPE; INTERMITTENT PREVENTIVE TREATMENT; LOW BIRTH WEIGHT; MALARIA; MUTATIONS; PARASITES; PLASMODIUM FALCIPARUM; POLYMORPHISMS; PREGNANCY; SEXTUPLE; SULFADOXINE-PYRIMETHAMINE; TANZANIA;

ADOLESCENT; ADULT; ALLELES; FEMALE; GESTATIONAL AGE; HAPLOTYPES; HUMANS; INFANT, LOW BIRTH WEIGHT; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; TANZANIA; TETRAHYDROFOLATE DEHYDROGENASE; YOUNG ADULT;

EID: 84882586896     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1909.130133     Document Type: Article

References (35)

1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93-104. http://dx.doi.org/10.1016/S1473-3099(07)70021-X
2. World Health Organization, Regional Office for Africa, Brazzaville, 2004. A strategic framework for malaria prevention and control during pregnancy in the African region. 2004 [cited 2013 Jun 12]. http://whqlibdoc.who.int/afro/2004/AFR_MAL_04.01.pdf
3. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. Am J Trop Med Hyg. 2004;70:1-7.
4. Ministry of Health and Social Welfare, United Republic of Tanzania. National guidelines for malaria diagnosis and treatment. 2006 [cited 2013 Jun 12]. http://apps.who.int/medicinedocs/en/m/ abstract/Js19271en/
5. Ramharter M, Schuster K, Bouyou-Akotet MK, Adegnika AA, Schmits K, Mombo-Ngoma G, et al. Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Am J Trop Med Hyg. 2007;77:418-22.
6. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux ME. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg. 2000;94:549-53. http://dx.doi.org/10.1016/S0035-9203(00)90083-X
7. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebocontrolled trial. Lancet. 1999;353:632-6. http://dx.doi.org/10.1016/ S0140-6736(98)07318-8
8. ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulphadoxinepyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297:2603-16. http://dx.doi.org/10.1001/jama.297.23.2603
9. van Eijk AM, Ayisi JG, ter Kuile FO, Otieno JA, Misore AO, Odondi JO, et al. Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health. 2004;9:351-60. http://dx.doi.org/10.1111/j.1365-3156.2004.01196.x
10. Bzik DJ, Li WB, Horii T, Inselburg J. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc Natl Acad Sci U S A. 1987;84:8360-4. http://dx.doi.org/10.1073/pnas.84.23.8360
11. Sibley CH, Hyde JE, Sims PFG, Plowe CV, Kublin JG, Mberu EK, et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 2001;17:582-8. http:// dx.doi.org/10.1016/S1471-4922(01)02085-2
12. Hyde JE. Point mutations and pyrimethamine resistance in Plasmodium falciparum. Parasitol Today. 1989;5:252-5. http://dx.doi. org/10.1016/0169-4758(89)90257-3
13. Kyabayinze D, Cattamanchi A, Mamya MR, Rosenthal PJ, Dorsey G. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Am J Trop Med Hyg. 2003;69:247-52.
14. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380-8. http://dx.doi. org/10.1086/338566
15. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, et al. High resistance of Plasmodium falciparum to sulphadoxine/ pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at codon 581. PLoS ONE. 2009;4:e4569. http://dx.doi.org/10.1371/journal.pone.0004569
16. World Health Organization. WHO policy recommendation on intermittent preventive treatment during infancy with sulphadoxinepyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. 2010 [cited 2013 Jun 12]. http://www.who.int/ malaria/news/WHO_policy_recommendation_IPTi_032010.pdf
17. World Health Organization; WHO Evidence Review Group. Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP). 2012 [cited 2013 Jun 12]. http://www.who. int/malaria/mpac/sep2012/iptp_sp_erg_meeting_report_july2012.pdf
18. Harrington WE, Morrison R, Fried M, Duffy PE. Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring. PLoS ONE. 2013;8:e56183. http://dx.doi.org/10.1371/journal.pone.0056183
19. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011;53:224-30. http://dx.doi.org/10.1093/cid/cir376
20. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, et al. Competitive facilitation of drugresistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A. 2009;106:9027-32. http://dx.doi.org/10.1073/pnas.0901415106
21. Mmbando BP, Vestergaard L, Kitua A, Lemnge M, Theander T, Lusingu J. A progressive declining in the burden of malaria in north-eastern Tanzania. Malar J. 2010;9:216. http://dx.doi. org/10.1186/1475-2875-9-216
22. Minja DT, Schmiegelow C, Oesterholt M, Magistrado P, Bostrom S, John D, et al. Reliability of rapid diagnostic tests in diagnosing pregnancy-associated malaria in north-eastern Tanzania. Malar J. 2012;11:211. http://dx.doi.org/10.1186/1475-2875-11-211
23. Schmiegelow C, Scheike T, Oesterholt M, Minja D, Pehrson C, Magistrado P, et al. Development of a fetal weight chart using serial trans-abdominal ultrasound in an East African population: a longitudinal observational study. PLoS ONE. 2012;7:e44773. http://dx.doi. org/10.1371/journal.pone.0044773
24. Schmiegelow C, Minja D, Oesterholt M, Pehrson C, Suhrs H, Boström S, et al. Factors associated with and causes of perinatal mortality in northeastern Tanzania. Acta Obstet Gynecol Scand. 2012;91:1061-8. http://dx.doi.org/10.1111/j.1600-0412.2012.01478.x
25. Schmiegelow C, Minja D, Oesterholt M, Pehrson C, Suhrs HE, Boström S, et al. Malaria and fetal growth alterations in the 3rd trimester of pregnancy: a longitudinal ultrasound study. PLoS ONE. 2013;8:e53794. http://dx.doi.org/10.1371/journal.pone.0053794
26. Wooden J, Kyes S, Sibley CH. PCR and strain identification in Plasmodium falciparum. Parasitol Today. 1993;9:303-5. http://dx.doi.org/10.1016/0169-4758(93)90131-X
27. Snounou G, Viriyakosol S, Xin PZ, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315-20. http://dx.doi.org/10.1016/0166-6851(93)90077-B
28. Jafari S, Bras JL, Bouchaud O, Durand R. Plasmodium falciparum clonal population dynamics during malaria treatment. J Infect Dis. 2004;189:195-203. http://dx.doi.org/10.1086/380910
29. Alifrangis M, Enosse S, Pearce R, Drakeley C, Roper C, Khalil IF, et al. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction-and enzyme-linked immunosorbent assay-based technology. Am J Trop Med Hyg. 2005;72:155-62.
30. Adebami OJ, Owa JA, Oyedeji GA, Oyelami OA, Omoniyi-Esan GO. Associations between placental and cord blood malaria infection and fetal malnutrition in an area of malaria holoendemicity. Am J Trop Med Hyg. 2007;77:209-13.
31. Griffin JB, Lokomba V, Landis S, Thorp J, Herring A, Tshefu A, et al. Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study. Malar J. 2012;11:319. http://dx.doi.org/10.1186/1475-2875-11-319
32. Umbers AJ, Stanisic DI, Ome M, Wangnapi R, Hanieh S, Unger HW, et al. Does malaria affect placental development? Evidence from in vitro models. PLoS ONE. 2013;8:e55269. http://dx.doi.org/10.1371/ journal.pone.0055269
33. World Health Organization. World malaria report 2012 [cited 2013 Jun 12]. http://www.who.int/malaria/publications/world_malaria_ report_2012/wmr2012_full_report.pdf
34. Peters PJ, Thigpen MC, Parise ME, Newman RD. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf. 2007; 30:481-501. http://dx.doi.org/10.2165/00002018-200730060-00003
35. Manyando C, Kayentao K, D'Alessandro U, Okafor H, Juma E, Hamed K. A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. Malar J. 2012;11:141. http://dx.doi.org/10.1186/1475-2875-11-141